Society for Pediatric Pain Medicine
Better Care for Children in Pain

The Society for Pediatric Pain Medicine (SPPM) aims to advance the quality of anesthesia care and the alleviation of pain-related conditions in children.

Society for Pediatric
Pain Medicine

Better Care for Children in Pain

Member Menu

  • Member Login
  • Forgot Password?
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
  • Home
  • About
    • Vision Statement
    • Board of Directors
    • Committees
      • Advocacy Committee
      • Communications Committee
      • Education Committee
      • Finance & Membership Committee
      • Research Committee
    • Special Interests Groups (SIGs)
      • Special Interest Group: Creating, Maintaining, and Supporting New Inpatient Pediatric Pain Services
      • Interdisciplinary Chronic Pain Treatment (ICPT) SIG
    • SPPM Bylaws
    • FAQs
    • Contact
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibitor Information
  • Education
    • Questions of the Month
    • SPPM Visual Pearls
    • Case Reports
    • Books for Clinicians
  • Membership
    • Member Benefits
    • Membership Classifications
    • New Member Spotlight
    • Renew Your Dues
    • Join Now
  • Resources
    • Latest News
    • Newsletters
    • COVID-19 Resources
    • Publications
    • Job Postings
    • Links of Interest
  • Patients & Families
    • Useful Links
    • Books for Patients and Families
    • Mobile Apps
    • FAQs
  • Trainees
    • Pediatric Chronic Pain Fellowship Programs
    • Pediatric Acute Pain/Regional Anesthesia Fellowship Programs

SPPM/SPA Response to FDA Regarding the Use of Codeine

In 2013 the FDA recommended against the use of codeine in pain medication, or as an antitussive in children less than 12 years of age. In 2015 and 2017 it strengthened its warnings; leading to a contraindication and label changes on codeine containing medications. Click here to view the recommendation.

At that time, they added warnings to the use of codeine in children less than 18. This was done because of the increased risk of side effects including difficulty breathing and death in children who had received codeine. A recent citizen’s petition is asking the FDA to remove these warnings and recommend that children get genetic testing to see if codeine is safe to use in them. The SPPM is strongly opposed to this move and along with leaders for the Society for Pediatric Anesthesia and other leading experts wrote a strong letter in opposition of relaxing these restrictions. Genetic testing is not widely available, it is not reliable, and it is often not covered by insurance companies. Relaxing these restrictions is not the answer to improved access to pain medications at this time. Without easily available, reliable and affordable testing, increased use of codeine will lead to increased complications and even death in children.

Upcoming Meeting Information

SPPM 11th Annual Meeting
April 11, 2024
Anaheim Marriott
Anaheim, CA

 

Join SPPM
Renew
Donate
Get Involved
Upcoming
Job Postings
Return to top of page
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2023 Society for Pediatric Pain Medicine | View Privacy Policy